Table 1.
Patient characteristic | Number of patients (%) |
---|---|
Age | Median 51 (range 37–75) |
Histology | |
Infiltrating ductal carcinoma | 22 (81%) |
Infiltrating lobular carcinoma | 4 (15%) |
Estrogen receptor | |
Positive | 6 (22%) |
Negative | 16 (59%) |
Unknown | 5 (19%) |
Progesterone receptor | |
Positive | 7 (26%) |
Negative | 14 (52%) |
Unknown | 6 (22%) |
Her2neu | |
Not amplified | 5 (19%) |
Amplified | 12 (44%) |
Unknown | 10 (37%) |
T stage | |
T0 | 1 (4%) |
T1 | 9 (33%) |
T2 | 8 (30%) |
T3 | 5 (19%) |
T4 | 3 (11%) |
Lymph nodal involvement | |
N0 | 9 (33%) |
N1 | 6 (22%) |
N2 | 8 (30%) |
N3 | 3 (11%) |